Abstract
In recent years, advances in molecular diagnostics have transformed the management of advanced non-small-cell lung cancer (NSCLC), allowing for increasingly personalized approaches [...].
MeSH terms
-
Carcinoma, Non-Small-Cell Lung* / drug therapy
-
Carcinoma, Non-Small-Cell Lung* / therapy
-
Humans
-
Lung Neoplasms* / drug therapy
-
Lung Neoplasms* / therapy
-
Molecular Targeted Therapy
-
Precision Medicine
Grants and funding
This research received no external funding.